Quick Summary
Indian Opinion Analysis
This research highlights critically importent progress in understanding drug-resistant epilepsy linked to FCD type 2, particularly its genetic foundation.For India-a country with a ample burden of neurological disorders-such studies could inspire more targeted diagnostic adn treatment strategies within its healthcare system. Incorporating insights like those about somatic variants into clinical practice might help improve care for affected individuals. However, advancing such research domestically may require increased investment in medical genetics infrastructure and stronger international collaborations to translate findings into actionable outcomes at scale.